F. Ratjen (Toronto, Canada), S. Cunningham (Edinburgh, United Kingdom)
Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF)
M. Cohen-Cymberknoh, Y. Yaakov, E. Kerem, D. Shoseyov, J. Rivlin, L. Bentur, E. Picard, M. Aviram, M. Wilschanski (Jerusalem, Haifa, Beer Sheva, Israel)
|  |
Regulation of ion transporters and airway surface dynamics by lipoxin in cystic fibrosis bronchial epithelium
M. Al-Alawi, V. Verriere, R. Chostello, V. Urbach, B. Harvey (Dublin, Ireland)
| |
Deficient production of IFN-stimulated genes upon rhinovirus infection in cystic fibrosis airway epithelial cells
E. Kieninger, M. Vareille, M. P. Alves, B. S. Kopf, T. Geiser, S. L. Johnston, M. R. Edwards, N. Regamey (Bern, Switzerland; London, United Kingdom)
| |
Association of FCN1 and FCN2 gene polymorphisms with earlier onset of chronic pseudomonas aeruginosa (Pa) colonisation in cystic fibrosis (CF) patients
F. Haerynck, K. Van Steen, T. Cattaert, B. Loeys, S. Van Daele, P. Schelstraete, F. De Baets (Ghent, Liege, Antwerp, Belgium)
|   |
The polyamine spermine is increased in cystic fibrosis airway secretions
H. Grasemann, D. Shehnaz, P. Pencharz, F. Ratjen (Toronto, Canada)
| |
Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis
J. Taytard, C. Rebeyrol, D. Debray, A. Clement, N. Chignard, P. Le Rouzic (Paris, France)
| |
The value of lung function monitoring by means of a home monitor in patients with cystic fibrosis
C. Robroeks, Q. Jöbsis, H. Hendriks, E. Dompeling (Maastricht, Netherlands)
| |
Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
F. McCourt, B. O‘Neill, I. Logan, J. Abbott, E. McCrum-Gardner, S. McKeown, J. Bradley, S. Elborn (Jordanstown, Preston, Belfast, United Kingdom)
| |